Back to Agenda
Round Table Discussion: Artificial Intelligence: Real Applications and Regulatory Perspectives
Session Chair(s)
Jeremy Jokinen, PhD, MS
Vice President and Head, Safety Evidence and Sciences
Bristol-Myers Squibb Company, United States
Join DIA Clinical Safety and Pharmacovigilance Community for a round table discussion tied to session #502 OD Artifical Intelligence: Real Applications and Regulatory Perspectives. Space is limited. When the virtual room is full, attendees attempting to access the session will receive a message noting that the session has reached maximum capacity.
Speaker(s)
Sameen Desai, MBA, MS
Bristol-Myers Squibb Company, United States
Executive Director, IT Worldwide Patient Safety
Tom Sabo, MS
SAS Institute Inc., United States
Principal Solutions Architect
Raj Ratwani, PhD
MedStar Health Research Institute, United States
Vice President of Scientific Affairs
Qais Hatim, PhD
FDA, United States
Data Scientist, OTS, CDER
Have an account?